WaveTalks

Auropharma - Pennant Push Above 700 to 725

Long
WaveTalks Updated   
NSE:AUROPHARMA   AUROBINDO PHARMA
There is a pennant where auropharma is resting. Let it rest, once it crosses 700-705 resistance keep a watch for a push to 722-725 Target Zone keeping stop loss below 687.

Risky Trader can consider to trade in 690-695 but with strict stop loss & once you get confirmation at your end.

Safe Traders Above 700-705 Zone for 722-725 Target Zone- once it crosses the zone it should not trade below 700 back again.
Trade active:
14:25 Hrs 11th Aug2017

Last Price@693 Risky Traders are in the call.

It was fast -Risky Traders got in at 688 - Stops were 687 that was just 1 point. It was too fast to react post the idea published.

Stop loss level-687

Going below 687 - They will lose 1-2 points which is ok from Trading point of View.

Trade active:
14:55 Hrs 11th Aug2017

Last Price@697

About to cross 700 - 1st level - above 705 will be a nice move for 720-725 zone.

Got 3 chances to enter this trade. Market can't give more chances.

Trade active:
15:02 Hrs 11th Aug2017

Last Price@697

700 could be 1st target for risky traders.
Trade active:
15:15 Hrs 11th Aug2017

Last Price@708

Heading for next target zone.

Trade active:
08:00 Hrs 14th Aug2017

Good Morning!

Last Price@705

Happy to pick with 1 point risk@687 on 11th Aug2017. Holding above 700-705 - we expect Auro to touch 722-725 minimum target & can extend upside if it stays above 725 for 15-20 mins.
Trade active:
09:20 Hrs 14th Aug2017

Last Price@714

Touches 721 just below 722 - we are done & out for short term.

Trade closed: target reached:
Target reached - Closed @14th Aug2017

Best Regards,
Abhishek H. Singh
​Growth Director - TradingView India

YouTube Channel www.youtube.com/channel/UCYcnYveYBNLD-Qp54hvZogw

Twitter Handle
twitter.com/TalksWave

Telegram Handle
(Deleted)
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.